中性粒细胞抗原呈现重新编程瘤微环境,并引起持久和广泛的抗瘤免疫力
Huan Wang1, Qi Meng2, Yoshimasa Ito2
1Brigham and Women's Hospital Boston, Massachusetts United States.
Cancer research communications
|February 9, 2026
概括
抗体-抗原结合物将中性粒细胞重新编程为呈现抗原的细胞,增强CD8+T细胞对固体瘤的免疫力,并提高抗PD-1疗法的有效性.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 癌症免疫疗法癌症免疫疗法
背景情况:
- 固体瘤会产生一种免疫抑制的微环境,阻碍免疫治疗的有效性.
- 功能障碍的树突细胞和抑制性中性粒细胞有助于免疫逃避.
- 中性粒细胞可以作为抗原呈现细胞 (nAPC),与更好的癌症预后相关.
研究的目的:
- 调查抗体-抗原结合物 (AAC) 是否可以将中性粒细胞重新编程成nAPC.
- 评估AACs在克服固体瘤中免疫抑制的治疗潜力.
- 探索AAC增强抗瘤免疫力和组合疗法的机制.
主要方法:
- 开发了一种静脉输送的抗体-抗原合物 (AAC),向中性粒细胞FcγRIIIB.
- 利用小鼠黑色素瘤模型来评估AAC治疗的疗效和免疫反应.
- 分析了T细胞激活,免疫细胞透,表皮质扩散以及脏和淋巴结的作用.
主要成果:
- AAC疗法成功地将中性粒细胞重新编程为nAPC,驱动CD8+T细胞激活.
- AAC治疗导致了持久的抗瘤免疫力,减少了肺和皮肤转移,并促进了表皮层的扩散.
- 脏对T细胞原始化至关重要,与抗PD-1的组合显著增强了瘤回归.
结论:
- AAC疗法提供了一种新的策略来重编程中性粒细胞,启动对固体瘤的强有力的T细胞免疫力.
- 这种方法可以克服免疫排斥,并与抗PD-1等检查点抑制剂协同作用.
- AACs代表了一种有前途的治疗途径,用于增强癌症免疫治疗结果.
更多相关视频
相关概念视频
The Tumor Microenvironment
7.9K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.9K
Antigens Involved in Adaptive Immunity
1.6K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
1.6K
Humoral Immune Responses
84.1K
Overview
84.1K
Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
Self-Presentation
325
Self-presentation is a fundamental aspect of social interaction, shaping both how others perceive individuals and how they view themselves. This dynamic process influences behaviors in various social settings, often leading people to adjust their appearance, speech, and demeanor to align with their desired identity. While self-presentation can be deliberate or unconscious, it plays a critical role in interpersonal relationships and self-perception.Forms of Self-PresentationSelf-presentation can...
325
Tumor Progression
7.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K


